Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ecker

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Idrugs : the Investigational Drugs Journal|December 24, 2003
EUFEPS 2002 - new safe medicines fasterGerhard Ecker
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Troxacitabine (Shire Pharmaceuticals)Gerhard Ecker
Archiv Der Pharmazie|January 16, 2026
A Proteochemometric Model for Ligands of the SLC5 Transporter FamilyMartin Juhás, Gerhard Ecker
Journal of Chemical Information and Computer Sciences|January 27, 2004
Topological distance based 3D descriptors for use in QSAR and diversity analysisChristian T Klein, Dominik Kaiser, Gerhard Ecker
Journal of Computer-Aided Molecular Design|November 26, 2003
MCASE study of the multidrug resistance reversal activity of propafenone analogsGilles Klopman, Hao Zhu, Gerhard Ecker, et al.
Future Medicinal Chemistry|June 26, 2014
'Big data' in pharmaceutical science: challenges and opportunitiesAl G Dossetter, Gerhard Ecker, Hugh Laverty, et al.
Journal of Chemical Information and Modeling|May 14, 2014
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictionsPau Carrió, Marta Pinto, Gerhard Ecker, et al.
International Journal of Antimicrobial Agents|September 19, 2003
Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeastManuela Schuetzer-Muehlbauer, Birgit Willinger, Ralf Egner, et al.
Journal of Chemical Information and Computer Sciences|September 28, 2004
Insights into phenylalanine derivatives recognition of VLA-4 integrin: from a pharmacophoric study to 3D-QSAR and molecular docking analysesAntonio Macchiarulo, Gabriele Costantino, Mirco Meniconi, et al.
Bioorganic & Medicinal Chemistry|October 7, 2004
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipMarek Murias, Norbert Handler, Thomas Erker, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|December 24, 2003
EUFEPS 2002 - new safe medicines fasterGerhard Ecker
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Troxacitabine (Shire Pharmaceuticals)Gerhard Ecker
Archiv Der Pharmazie|January 16, 2026
A Proteochemometric Model for Ligands of the SLC5 Transporter FamilyMartin Juhás, Gerhard Ecker
Journal of Chemical Information and Computer Sciences|January 27, 2004
Topological distance based 3D descriptors for use in QSAR and diversity analysisChristian T Klein, Dominik Kaiser, Gerhard Ecker
Journal of Computer-Aided Molecular Design|November 26, 2003
MCASE study of the multidrug resistance reversal activity of propafenone analogsGilles Klopman, Hao Zhu, Gerhard Ecker, et al.
Future Medicinal Chemistry|June 26, 2014
'Big data' in pharmaceutical science: challenges and opportunitiesAl G Dossetter, Gerhard Ecker, Hugh Laverty, et al.
Journal of Chemical Information and Modeling|May 14, 2014
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictionsPau Carrió, Marta Pinto, Gerhard Ecker, et al.
International Journal of Antimicrobial Agents|September 19, 2003
Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeastManuela Schuetzer-Muehlbauer, Birgit Willinger, Ralf Egner, et al.
Journal of Chemical Information and Computer Sciences|September 28, 2004
Insights into phenylalanine derivatives recognition of VLA-4 integrin: from a pharmacophoric study to 3D-QSAR and molecular docking analysesAntonio Macchiarulo, Gabriele Costantino, Mirco Meniconi, et al.
Bioorganic & Medicinal Chemistry|October 7, 2004
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipMarek Murias, Norbert Handler, Thomas Erker, et al.
Pageof 2